MedTrace Logo

Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis

NCT05086536 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-10-21

No results posted yet for this study

Summary

In this study, treatment-naïve HBV-related cirrhosis patients were retrospectively enrolled at the first episode of decompensation (ascites or variceal hemorrhage). Patients were followed up every 6 months until death /liver transplantation or for 5 years. Clinical data from medical records about past history, first decompensated events, second /further decompensated events, HCC, and death/ liver transplantation were retrospectively collected. In this retrospective study, the incidence of re-compensation and its clinical characteristics were mainly explored.

Conditions

Interventions

OTHER

no intervention

This is a retrospective and observational study.

Sponsors & Collaborators

  • Beijing YouAn Hospital

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • The Affiliated Hospital of Qingdao University

    collaborator OTHER

  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER

  • Xiangya Hospital of Central South University

    collaborator OTHER

  • The Second Affiliated Hospital of Baotou Medical College

    collaborator OTHER

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Hong You, Doctor · Beijing Friendship Hospita

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2022-06-01
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05086536 on ClinicalTrials.gov